Organization
Genomic Health, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Genomic Health, Inc.
... may want it, and 12% were unsure. Results are based on Wamberg Genomic Consumer Survey, which queried 536 U.S. consumers from 26 to 64 years ...
... Genomic Health, Inc. (NASDAQ: GHDX) today announced a multi-year research collaboration agreement with Janssen Pharmaceuticals ...
... Sciences, ANGLE plc, Illumina, Inc., Menarini Silicon Biosystems., MDxHealth, Sysmex Inostics GmbH, Genomic Health, and NeoGenomics Laboratories, Inc. The report presents the reader with an ...
... Genomic Health, Inc. (Nasdaq: GHDX)7) prior to prostate biopsy. The goal is to reduce unnecessary ...
... Genomic Health, Inc. (NASDAQ: GHDX) today announced that it will present at the 29th Annual ...
... commercialization of the Idylla(TM) platform on the US market. - Strategic collaboration Genomic Health: Exclusive agreement signed with Genomic Health to develop an IVD version ...
... Laboratories International Inc., SYNLAB International GmbH, Sonic Healthcare, NeoGenomics Laboratories Inc., Genomic Health Inc., Fresenius Medical Care, Laboratory Corporation of America Holdings, UNILABS, Quest Diagnostics ...
... would like to have it, and 38% are considering it. The Wamberg Genomic Survey was fielded by Survey Sampling International (SSI), a premier global provider ...
... diagnostic developers: - MDxHealth (formerly OncoMethylome) - Epigenomics - Critical Diagnostics - Genomic Health - Myriad Genetics - Quest Diagnostics - Thermo Fisher Scientific - ...
... in many patients. To support the hypothesis of tumor heterogeneity, single cell genomic profiling identified genomic heterogeneity associated with the protein heterogeneity which has been ...
... thyroid and other cancers. Whether it's called precision medicine, personalized medicine or genomic health care, the idea is to tailor medical care, eschewing a traditional ...
... market will witness few trends such as introduction of new pharmacologic agents, Genomic medicines and growing trend of strategic alliances and acquisitions. ?-Adrenoceptor antagonists (?-blockers) ...
... 2020"report has been added toResearch and Markets'offering. Will all newborns receive Whole Genomic Sequencing at birth? How fast will Direct to Consumer Testing grow? Our ...
... The"In Vitro Diagnostic Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department by Country. ...
... Assays 4.23 Biocept, Rosetta Genomics Partner to Profile microRNAs from CTCs 4.22 Genomic Health Reports 5 Percent Revenue Growth in Third Quarter 4.21 HTG Molecular ...
... The "In Vitro Diagnostic Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department by Country. ...
... diagnostic laboratory tests (ADLTs) which will serve as a catalyst for innovative genomic diagnostics that benefit patients by personalizing medical treatment decisions. About C21 C21's ...
... The "Medical Laboratory Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department by Country. ...
... At least one market research firm thinks that Genomic Health's deal with Biocartis may not only assist the company with reaching ...
... by a ROS1 mutation. Dr Staudt is working on a repository for genomic information called the NCI Genomic Data Commons, which hopes to identify more ...
... Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests andBiocartisGroup NV ...
... towards advancing precision medicine in preventive care. Ambry is collaborating with NorthShore's Genomic Health Initiative (GHI) by performing Whole Exome Sequencing (WES) on 10,000 enrolled ...
... Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of new data that provide additional ...
... without enrichment. In addition, a subset of samples was analyzed with single-cell genomic sequencing, which is impractical to perform in a diagnostic setting due to ...
Want to see the full history on Genomic Health, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial